Remus Pharmaceuticals Share Price Today | Stock Price & Remus Pharmaceuticals Share Screener

Track the current stock price of Remus Pharmaceuticals with an interactive chart. Analyse REMUS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Remus Pharmaceuticals stock quote in one place.

Screen Remus Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for REMUS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0O5T01011.

Classification

Identifiers and Leadership

Screen REMUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹579, up from ₹433 in 2025.

Latest statistics put total assets at ₹579 and shareholder funds at ₹351, with a leverage ratio of 0.09.

Screen Remus Pharmaceuticals income statement and profit fundamentals. Analyze REMUS quarterly results. Remus Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹854 and net profit of ₹46.

Screen REMUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹7, and net cash flow was an inflow of ₹3.

Over the same period, investing activities used ₹11 and financing activities provided ₹6.

See Remus Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Remus Pharmaceuticals promoter holding and ownership changes for REMUS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 70.95%, foreign institutions 5.28%, domestic institutions 0.83% and the public 18.50%, spread across 2,009 shareholders.

The shareholder count was 2,009 in 2026-Mar, compared with 2,032 in 2025-Sept.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Remus Pharmaceuticals. Remus Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹1.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹1.50 and ₹0.00 per unit.

See which indices include Remus Pharmaceuticals stock. Check REMUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Remus Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Remus Pharmaceuticals stock events that may affect REMUS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Dividend dated September 22, 2026, with a record date of September 22, 2026.

It is followed by Quarterly Result Announcement dated May 20, 2026 and Dividend dated November 14, 2025.

Screen REMUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen REMUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.